Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MERTK (clone M1G1G). We employs the Adenovirus (T7-GFP-NF-κB-BamHI) vector components and the SynExpress system of the miRNA Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
MERTK
Clone
M1G1G
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
NF-κB
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
Adenovirus
Transformation Accuracy
0.92
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.